Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.53 |
| ▸ | ELANE | P08246 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 9/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6638083 | 0.91 | CTRB1 (0.52) | CTRB1ELANEKMT2AALDH1A1CYP3A4 | |
| SCHEMBL6635088 | 0.89 | CTRB1 (0.51) | CTRB1ELANEBACE1ALDH1A1CYP3A4 | |
| SCHEMBL6641379 | 0.88 | CTRB1 (0.53) | CTRB1ELANEKMT2AALDH1A1MAPT | |
| SCHEMBL6637258 | 0.86 | CTRB1 (0.51) | CTRB1ELANECYP17A1 | |
| SCHEMBL6635091 | 0.86 | CTRB1 (0.54) | CTRB1ELANEKMT2ABACE1CYP17A1 | |
| SCHEMBL6637522 | 0.84 | CTRB1 (0.47) | CTRB1ELANEKMT2ACYP17A1ALDH1A1 | |
| SCHEMBL6637009 | 0.83 | CTRB1 (0.52) | CTRB1ELANEKMT2AALDH1A1CYP3A4 | |
| SCHEMBL6400204 | 0.83 | ELANE (0.65) | CTRB1ELANEMAPTPOLB | |
| SCHEMBL6634775 | 0.81 | CTRB1 (0.50) | CTRB1ELANEKMT2ACYP3A4LMNA | |
| SCHEMBL6638871 | 0.79 | ELANE (0.61) | CTRB1ELANEKMT2ABACE1CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |